The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Climara 50 micrograms/24 hours Transdermal Patch



Bayer LimitedPA1410/015/001

Main Information

Trade NameClimara 50 micrograms/24 hours Transdermal Patch
Active SubstancesEstradiol
Dosage FormTransdermal patch
Licence HolderBayer Limited
Licence NumberPA1410/015/001

Group Information

ATC CodeG03CA Natural and semisynthetic estrogens, plain
G03CA03 estradiol

Status

License statusAuthorised
Licence Issued25/07/1996
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicencePatient Information Warning for Patients 1. While you are receiving this medication, you should see your doctor regularly, at least every 6 to 12 months. 2. If you have any unusual symptoms such as unexplained pains in the chest, abdomen or legs you must consult your doctor immediately. 3. Patients with a family history of breast cancer should use the medication with great caution
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back